1 active not recruiting, 1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Cholinesterase Inhibitors: new trials by email Literature Review of Cholinesterase Inhibitors trials Research Report on Cholinesterase Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) cholinesterase inhibitors (CI) (donepezil, galantamine or rivastigmine) - Alzheimer Disease, Cholinesterase Inhibitors | Phase 4 | Not yet recruiting | University Hospital, Bordeaux | 1205 | 2024-06-01 | 2023-10-06 |
| Dementia and Kidney Disease: Epidemiological Approaches to Risk Factors and Treatment Strategies Kidney disease - Chronic Kidney Disease, Acute Kidney Injuries | Active not recruiting | Karolinska Institutet | 200000 | 2007-01-01 | 2025-08-03 |
Alzheimer Disease (2) · Acute Kidney Injury (1) · Cognitive Dysfunction (1) · Dementia (1) · Renal Insufficiency, Chronic (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Tauopathies (2) · Chronic Disease (1) · Cognition Disorders (1) · Dementia (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1)
Cholinesterase Inhibitors (1) · Donepezil (1) · Galantamine (1) · Rivastigmine (1)
Karolinska Institutet (1) · University Hospital, Bordeaux (1)
France (1) · Sweden (1)
Hong Xu (1)